Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ARTVCompany Name
ARTIVA BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARTIVA BIOTHERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ARTV - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.51M | 0% | $ 0 |
| 3/31/2025 | $ 2.47M | 0% | $ 0 |
| 12/31/2024 | $ 2.43M | 968.53% | $ 251K |
| 12/31/2023 | $ 2.27M | 6.77% | $ 33.49M |
Key Performance Insights, Last 5 Years
- ARTIVA BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 6.77%.
- Over the past 5 years, ARTIVA BIOTHERAPEUTICS INC's average DepAmor % has been 487.65%.
- The median DepAmor % for ARTIVA BIOTHERAPEUTICS INC during this period was 487.65%
- ARTIVA BIOTHERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 968.53%.
- The lowest DepAmor % recorded by ARTIVA BIOTHERAPEUTICS INC in the same timeframe 6.77%
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ARTIVA BIOTHERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.27M ] / Revenues [ $ 33.49M ]
(=) DepAmor % [ 6.77% ] ARTV - Depreciation and Amortization Margin, Last 5 years
6.77%
Minimum
Dec 31, 2023
968.53%
Maximum
Dec 31, 2024
487.65%
Average
487.65%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |